Condensed Statements of Stockholders Equity - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2018	27,364,607
Beginning balance, amount at Dec. 31, 2018	$ 2,736	$ 16,791,254	$ (4,404,336)	$ 12,389,654
Sale of common stock and warrants at $6.50 per share in public offering, net of issuance costs, shares	1,923,076
Sale of common stock and warrants at $6.50 per share in public offering, net of issuance costs, amount	$ 192	11,351,022		11,351,214
Common shares issued upon exercise of warrants at $3.00 per share, shares	62,150
Common shares issued upon exercise of warrants at $3.00 per share, amount	$ 6	186,444		186,450
Common shares issued upon exercise of warrants at $5.00 per share, shares	274,167
Common shares issued upon exercise of warrants at $5.00 per share, amount	$ 28	1,370,807		1,370,835
Common shares issued upon exercise of stock options, shares	16,250
Common shares issued upon exercise of stock options, amount	$ 2	24,373		24,375
Stock-based compensation expense		600,898		600,898
Net loss for the period			(3,394,855)	(3,394,855)
Ending balance, shares at Jun. 30, 2019	29,640,250
Ending balance, amount at Jun. 30, 2019	$ 2,964	30,324,798	(7,799,191)	22,528,571
Beginning balance, shares at Mar. 31, 2019	27,364,607
Beginning balance, amount at Mar. 31, 2019	$ 2,736	17,018,301	(5,885,117)	11,135,920
Sale of common stock and warrants at $6.50 per share in public offering, net of issuance costs, shares	1,923,076
Sale of common stock and warrants at $6.50 per share in public offering, net of issuance costs, amount	$ 192	11,351,022		11,351,214
Common shares issued upon exercise of warrants at $3.00 per share, shares	62,150
Common shares issued upon exercise of warrants at $3.00 per share, amount	$ 6	186,444		186,450
Common shares issued upon exercise of warrants at $5.00 per share, shares	274,167
Common shares issued upon exercise of warrants at $5.00 per share, amount	$ 28	1,370,807		1,370,835
Common shares issued upon exercise of stock options, shares	16,250
Common shares issued upon exercise of stock options, amount	$ 2	24,373		24,375
Stock-based compensation expense		373,851		373,851
Net loss for the period			(1,914,074)	(1,914,074)
Ending balance, shares at Jun. 30, 2019	29,640,250
Ending balance, amount at Jun. 30, 2019	$ 2,964	30,324,798	(7,799,191)	22,528,571
Beginning balance, shares at Dec. 31, 2019	29,829,916
Beginning balance, amount at Dec. 31, 2019	$ 2,983	31,922,493	(12,729,824)	19,195,652
Sale of common stock and warrants at $6.00 per share in public offering, net of issuance costs, shares	2,066,667
Sale of common stock and warrants at $6.00 per share in public offering, net of issuance costs, amount	$ 207	11,666,999		11,667,206
Common shares issued upon exercise of warrants at $3.00 per share, shares	150,504
Common shares issued upon exercise of warrants at $3.00 per share, amount	$ 15	439,973		439,988
Common shares issued upon exercise of warrants at $5.00 per share, shares	1,851,003
Common shares issued upon exercise of warrants at $5.00 per share, amount	$ 185	8,868,263		8,868,448
Common shares issued upon exercise of warrants at $6.50 per share, shares	83,693
Common shares issued upon exercise of warrants at $6.50 per share, amount	$ 8	543,997		544,005
Common shares issued upon exercise of stock options, shares	293,250
Common shares issued upon exercise of stock options, amount	$ 29	514,846		514,875
Common shares issued upon vesting of restricted stock units, shares	86,558
Common shares issued upon vesting of restricted stock units, amount	$ 9	(9)		0
Stock-based compensation expense		1,016,235		1,016,235
Net loss for the period			(5,162,478)	(5,162,478)
Ending balance, shares at Jun. 30, 2020	34,361,591
Ending balance, amount at Jun. 30, 2020	$ 3,436	54,972,797	(17,892,302)	37,083,931
Beginning balance, shares at Mar. 31, 2020	30,073,724
Beginning balance, amount at Mar. 31, 2020	$ 3,007	33,191,001	(15,075,799)	18,118,209
Sale of common stock and warrants at $6.00 per share in public offering, net of issuance costs, shares	2,066,667
Sale of common stock and warrants at $6.00 per share in public offering, net of issuance costs, amount	$ 207	11,666,999		11,667,206
Common shares issued upon exercise of warrants at $3.00 per share, shares	138,721
Common shares issued upon exercise of warrants at $3.00 per share, amount	$ 14	404,625		404,639
Common shares issued upon exercise of warrants at $5.00 per share, shares	1,731,603
Common shares issued upon exercise of warrants at $5.00 per share, amount	$ 173	8,271,275		8,271,448
Common shares issued upon exercise of warrants at $6.50 per share, shares	83,693
Common shares issued upon exercise of warrants at $6.50 per share, amount	$ 8	543,997		544,005
Common shares issued upon exercise of stock options, shares	180,625
Common shares issued upon exercise of stock options, amount	$ 18	345,920		345,938
Common shares issued upon vesting of restricted stock units, shares	86,558
Common shares issued upon vesting of restricted stock units, amount	$ 9	(9)		0
Stock-based compensation expense		548,989		548,989
Net loss for the period			(2,816,503)	(2,816,503)
Ending balance, shares at Jun. 30, 2020	34,361,591
Ending balance, amount at Jun. 30, 2020	$ 3,436	$ 54,972,797	$ (17,892,302)	$ 37,083,931